425 related articles for article (PubMed ID: 22378628)
1. Rhabdomyosarcoma: review of the Children's Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies.
Malempati S; Hawkins DS
Pediatr Blood Cancer; 2012 Jul; 59(1):5-10. PubMed ID: 22378628
[TBL] [Abstract][Full Text] [Related]
2. Local control and outcome in children with localized vaginal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma committee of the Children's Oncology Group.
Walterhouse DO; Meza JL; Breneman JC; Donaldson SS; Hayes-Jordan A; Pappo AS; Arndt C; Raney RB; Meyer WH; Hawkins DS
Pediatr Blood Cancer; 2011 Jul; 57(1):76-83. PubMed ID: 21298768
[TBL] [Abstract][Full Text] [Related]
3. Children's Oncology Group's 2023 blueprint for research: Soft tissue sarcomas.
Oberoi S; Crane JN; Haduong JH; Rudzinski ER; Wolden SL; Dasgupta R; Linardic CM; Weiss AR; Venkatramani R;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30556. PubMed ID: 37430436
[TBL] [Abstract][Full Text] [Related]
4. Genitourinary rhabdomyosarcoma: which treatment, how much, and when?
Wu HY; Snyder HM; Womer RB
J Pediatr Urol; 2009 Dec; 5(6):501-6. PubMed ID: 19640790
[TBL] [Abstract][Full Text] [Related]
5. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
Meza JL; Anderson J; Pappo AS; Meyer WH;
J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036
[TBL] [Abstract][Full Text] [Related]
6. Progress in the diagnosis and treatment of rhabdomyosarcoma and related soft tissue sarcomas.
Ruymann FB; Grovas AC
Cancer Invest; 2000; 18(3):223-41. PubMed ID: 10754991
[TBL] [Abstract][Full Text] [Related]
7. Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: combined results from the Children's Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of Pediatric Oncology Malignant Mesenchymal Tumors Committee.
Rodeberg DA; Anderson JR; Arndt CA; Ferrer FA; Raney RB; Jenney ME; Brecht IB; Koscielniak E; Carli M; Bisogno G; Oberlin O; Rey A; Ullrich F; Stevens MC; Meyer WH
Int J Cancer; 2011 Mar; 128(5):1232-9. PubMed ID: 20473932
[TBL] [Abstract][Full Text] [Related]
8. An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials.
Haduong JH; Heske CM; Allen-Rhoades W; Xue W; Teot LA; Rodeberg DA; Donaldson SS; Weiss A; Hawkins DS; Venkatramani R
Pediatr Blood Cancer; 2022 Apr; 69(4):e29511. PubMed ID: 35129294
[TBL] [Abstract][Full Text] [Related]
9. Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Joshi D; Anderson JR; Paidas C; Breneman J; Parham DM; Crist W;
Pediatr Blood Cancer; 2004 Jan; 42(1):64-73. PubMed ID: 14752797
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and clinical impact of anaplasia in childhood rhabdomyosarcoma : a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Qualman S; Lynch J; Bridge J; Parham D; Teot L; Meyer W; Pappo A
Cancer; 2008 Dec; 113(11):3242-7. PubMed ID: 18985676
[TBL] [Abstract][Full Text] [Related]
11. Localized vaginal/uterine rhabdomyosarcoma-results of a pooled analysis from four international cooperative groups.
Minard-Colin V; Walterhouse D; Bisogno G; Martelli H; Anderson J; Rodeberg DA; Ferrari A; Jenney M; Wolden S; De Salvo G; Arndt C; Merks JHM; Gallego S; Schwob D; Haie-Meder C; Bergeron C; Stevens MCG; Oberlin O; Hawkins D;
Pediatr Blood Cancer; 2018 Sep; 65(9):e27096. PubMed ID: 29781567
[TBL] [Abstract][Full Text] [Related]
12. Future directions in risk stratification and therapy for advanced pediatric genitourinary rhabdomyosarcoma.
Harel M; Ferrer FA; Shapiro LH; Makari JH
Urol Oncol; 2016 Feb; 34(2):103-15. PubMed ID: 26519985
[TBL] [Abstract][Full Text] [Related]
13. Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology Group.
Hibbitts E; Chi YY; Hawkins DS; Barr FG; Bradley JA; Dasgupta R; Meyer WH; Rodeberg DA; Rudzinski ER; Spunt SL; Skapek SX; Wolden SL; Arndt CAS
Cancer Med; 2019 Oct; 8(14):6437-6448. PubMed ID: 31456361
[TBL] [Abstract][Full Text] [Related]
14. Adolescents and young adults with rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Harrison DJ; Qumseya A; Xue W; Arnold M; Lautz TB; Hiniker SM; Thomas SM; Venkatramani R; Weiss AR; Mascarenhas L
Pediatr Blood Cancer; 2024 Apr; 71(4):e30847. PubMed ID: 38282125
[TBL] [Abstract][Full Text] [Related]
15. Results in patients with cranial parameningeal sarcoma and metastases (Stage 4) treated on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols II-IV, 1978-1997: report from the Children's Oncology Group.
Raney B; Anderson J; Breneman J; Donaldson SS; Huh W; Maurer H; Michalski J; Qualman S; Ullrich F; Wharam M; Meyer W;
Pediatr Blood Cancer; 2008 Jul; 51(1):17-22. PubMed ID: 18266224
[TBL] [Abstract][Full Text] [Related]
16. Surgical management of paratesticular rhabdomyosarcoma: A consensus opinion from the Children's Oncology Group, European paediatric Soft tissue sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe.
Rogers TN; Seitz G; Fuchs J; Martelli H; Dasgupta R; Routh JC; Hawkins DS; Koscielniak E; Bisogno G; Rodeberg DA
Pediatr Blood Cancer; 2021 Apr; 68(4):e28938. PubMed ID: 33522706
[TBL] [Abstract][Full Text] [Related]
17. Rhabdomyosarcoma in children and adolescents. A review.
Ruymann FB
Hematol Oncol Clin North Am; 1987 Dec; 1(4):621-54. PubMed ID: 3323176
[TBL] [Abstract][Full Text] [Related]
18. Pathology of childhood rhabdomyosarcoma: A consensus opinion document from the Children's Oncology Group, European Paediatric Soft Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe.
Rudzinski ER; Kelsey A; Vokuhl C; Linardic CM; Shipley J; Hettmer S; Koscielniak E; Hawkins DS; Bisogno G
Pediatr Blood Cancer; 2021 Mar; 68(3):e28798. PubMed ID: 33306276
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of children and young adults with newly diagnosed rhabdomyosarcoma metastatic to bone marrow treated on Children's Oncology Group studies.
Schloemer NJ; Xue W; Qumseya A; Luo LY; Hiniker SM; Lautz TB; Rhee DS; Arnold MA; Venkatramani R
Pediatr Blood Cancer; 2023 Dec; 70(12):e30701. PubMed ID: 37783659
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
[No Abstract] [Full Text] [Related]
[Next] [New Search]